Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 5:21 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 1,872 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parkinson Disease Clear all

Conditions: Parkinson Disease
Interventions: Parkinson's Application, Digital Placebo Application; Device
Lead sponsor: Beats Medical; Industry
Eligibility: 30 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Parkinson Disease
Interventions: Motivational Interviewing, Web-based application; Behavioral
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Parkinson's Disease, Mild Cognitive Impairment
Interventions: Brain Fitness, InSight, Active Control; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 21 Years to 90 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Parkinson Disease
Interventions: AP-472, Placebo; Drug · Other
Lead sponsor: Appello Pharmaceuticals, Inc.; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 30
States / cities: Little Rock, Arkansas • Carlsbad, California • Los Alamitos, California + 25 more

Conditions: Parkinson's Disease
Interventions: Traditional Therapeutic Exercise, Non-Contact Boxing Training; Behavioral
Lead sponsor: University of Indianapolis; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Parkinson Disease, Gait Disorders, Neurologic, Parkinsonian Disorders, Movement Disorders, Gait, Unsteady, Gait, Festinating
Interventions: No Cue, Conventional Cue, Constant Cue, Patient hand-triggered, Patient eye-triggered, Examiner-triggered; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 21 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Parkinson Disease
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: 45 Years to 80 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Parkinson's Disease Patients Undergoing Deep Brain Stimulation (DBS) Surgery
Interventions: Measuring electrical signals from the brain; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Parkinson Disease
Interventions: Rhythmic Auditory Stimulation (RAS); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Parkinson's Disease
Interventions: Ketamine, Remimazolam; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Advanced/Metastatic Melanoma
Interventions: Gebasaxturev IV, Gebasaxturev ITu, Pembrolizumab; Biological · Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 4
States / cities: Detroit, Michigan • New Brunswick, New Jersey • Portland, Oregon + 1 more

Conditions: Parkinson Disease
Interventions: Computer task assessing cognition, Impulsive-Compulsive Disorders in Parkinson's Disease, Deep Brain Stimulation Surgery; Behavioral · Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 90 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Parkinson's Disease
Interventions: Kinesia HomeView; Device
Lead sponsor: Great Lakes NeuroTechnologies Inc.; Industry
Eligibility: Not listed
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Parkinson Disease
Interventions: Laser light (U-Step Walking Stabilizer with laser light); Device
Lead sponsor: Parkinson's Disease Research, Education, and Clinical Center, Philadelphia; Federal
Eligibility: Not listed
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Parkinson's Disease
Interventions: Gait training; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Parkinson Disease, Depressive Symptoms
Interventions: BIOPAC Stimsola, BIOPAC Stimsola Sham (zero amps); Device
Lead sponsor: University of South Alabama; Other
Eligibility: 19 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Mobile, Alabama

Conditions: Carcinoma, Hepatocellular
Interventions: Lenvatinib, Pembrolizumab, Oral Placebo, IV Placebo, TACE; Drug · Biological · Procedure
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 27
States / cities: Tucson, Arizona • La Jolla, California • Los Angeles, California + 22 more

Conditions: Parkinson Disease, Autonomic Dysfunction, Depression
Interventions: transcranial magnetic stimulation; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Parkinson Disease
Interventions: Gait training without rhythmic auditory cues, TRAC, dTRAC; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 50 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Parkinson's Disease
Interventions: AVE8112, Placebo; Drug
Lead sponsor: Michael J. Fox Foundation for Parkinson's Research; Other
Eligibility: 35 Years to 70 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Glendale, California • Baltimore, Maryland

Conditions: Parkinson's Disease, Obsessive Compulsive Disorder, Dystonia, Essential Tremor, Epilepsy
Interventions: Stereotactic brain procedures; Device
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 6 Years to 90 Years
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Parkinson, Epilepsy
Interventions: Activa PC+S; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Parkinson's Disease
Interventions: Deep Brain Stimulation; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Parkinson´s Disease
Interventions: Not listed
Lead sponsor: CENTOGENE GmbH Rostock; Industry
Eligibility: 30 Years to 80 Years
Enrollment: 20,112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 26
States / cities: Tucson, Arizona • Encino, California • Fresno, California + 23 more

Search by objective public record fields.

Pilot Study to Evaluate the Self-Management of Gait, Speech, and Dexterity Symptoms in Parkinson's Disease Using a Smartphone Application

Motivational Interviewing and Physical Activity Change in Parkinson's Disease

Computer-based Cognitive Training for Individuals With Parkinson's Disease

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Non-contact Boxing Training and Traditional Therapeutic Exercise for Persons With Parkinson's Disease

External vs Internal-triggered Augmented-reality Visual Cues to Treat Freezing of Gait

Pathways Mediating Impaired Postural Control in Parkinson's Disease

Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks

Effects of RAS on Gait in PD Patients With DBS

Ketamine for Veterans With Parkinson's Disease

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Neural Correlates of Cognition in Parkinson's Disease

Tele-diagnostics for Remote Parkinson's Monitoring

Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease

Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease

Low Voltage Electrical Stimulation for Depression in Parkinson's Patients

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Investigating Central Neurophysiologic Correlates of Non-Motor Symptoms of Parkinson's Disease

Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease

A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease

Physiological Brain Atlas Development

High Frequency Oscillations in Neurologic Disease

Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes

Rostock International Parkinson's Disease Study (ROPAD)